InvestorsHub Logo
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

Re: exwannabe post# 124105

Friday, 05/24/2013 4:49:15 PM

Friday, May 24, 2013 4:49:15 PM

Post# of 345969
Ex,

With all due respect your question was:

"So my question is, what is the factual basis of this deep respect?"

If you don't believe that by being the regulatory/compliance point man (i.e., the senior vice president of regulatory, quality and compliance) for shepherding the monoclonal antibody therapeutics Rituxan, Herceptin, Avastin and Lucentis through to FDA approval is not deserving of great respect in the pharmaceutical/biologics industry, then its my contention that your intention was as I thought it to be; you only wanted a soapbox reason to diminish the significance of having an industry heavyweight on our team. A heavyweight in our specific product area by the way.

You really can't be serious? However, I'm sure you'll provide quite rational (in your opinion anyway) reasons why he isn't deserving of great respect. After all its an obviously subjective question that allows anyone to answer with any type of self interested bias that they choose to apply to the response. At least my response was backed up with facts.

Sorry in advance to all the serious longs here for letting him have another shot at this. But, doesn't it just stretch credulity for someone not to accept Dr. Garnick's experience as a basis for deep respect in our specific corner of the pharmaceutical industry?

Ex, it certainly seemed obvious to me that my response was more than sufficient to answer your question and I would think that most people reading this board would agree.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News